Name | Ethyl 2,6-dichloronicotinate |
---|---|
Synonyms |
Ethyl 2,6-dichloronicotinate
Ethyl 2,6-dichloropyridine-3-carboxylate 3-Pyridinecarboxylic acid, 2,6-dichloro-, ethyl ester 2,6-Dichloronicotinic acid ethyl ester |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 286.0±35.0 °C at 760 mmHg |
Melting Point | 52° C |
Molecular Formula | C8H7Cl2NO2 |
Molecular Weight | 220.053 |
Flash Point | 126.7±25.9 °C |
Exact Mass | 218.985382 |
PSA | 39.19000 |
LogP | 2.43 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.541 |
Hazard Codes | Xn |
---|---|
HS Code | 2933399090 |
~67% 58584-86-4 |
Literature: NOVARTIS AG Patent: WO2009/150230 A1, 2009 ; Location in patent: Page/Page column 134 ; WO 2009/150230 A1 |
~% 58584-86-4 |
Literature: AstraZeneca AB Patent: US2008/171732 A1, 2008 ; Location in patent: Page/Page column 39-40 ; US 20080171732 A1 |
~% 58584-86-4 |
Literature: ASTRAZENECA AB Patent: WO2008/85119 A1, 2008 ; Location in patent: Page/Page column 184-185 ; WO 2008/085119 A1 |
~69% 58584-86-4 |
Literature: Meerpoel; Deroover; Van Aken; Lux; Hoornaert Synthesis, 1991 , # 9 p. 765 - 768 |
Precursor 5 | |
---|---|
DownStream 3 | |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |